packageUpadacitinib

upadacitinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Upadacitinib, a Janus kinase inhibitor, is used to treat inflammatory conditions such as rheumatoid and psoriatic arthritis, axial spondyloarthritis, giant cell arteritis, atopic dermatitis, ulcerative colitis, and Crohn disease. It is an approved, authorised medicine in the European Union and is widely used for these immune-mediated diseases.

Summary written by glm-5.3-flash from Wikidata Q27074125 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:upadacitinib
ATC codes:L04AA44, L04AF03
DrugBank:DB15091
PubChem CID:58557659
Wikidata:Q27074125
formula:C17H19F3N6O
molar mass:380.374 g/mol (PubChem CID 58557659)
logP:2.7 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown